Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202607554113342Not yet recruiting
Trial of dexamethasone in post-dural puncture headache (PDPH) (2 arms), sponsored by Auwalu Shuaibu. Primary endpoints: Prevention of post-dural puncture headache and Prevalence of post-dural puncture headache. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202607554113342.